UGT1A1 polymorphisms associated with prolactin response in risperidone-treated children and adolescents with autism spectrum disorder (Q89326546)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29955115%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

title

UGT1A1 polymorphisms associated with prolactin response in risperidone-treated children and adolescents with autism spectrum disorder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29955115%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

main subject

autism spectrum disorder

1 reference

Yaowaluck Hongkaew

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29955115%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Sadeep Medhasi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29955115%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Ekawat Pasomsub

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29955115%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Nattawat Ngamsamut

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29955115%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Apichaya Puangpetch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29955115%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Natchaya Vanwong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29955115%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Monpat Chamnanphon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29955115%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Penkhae Limsila

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29955115%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Chuthamanee Suthisisang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29955115%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Bob Wilffert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29955115%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Chonlaphat Sukasem

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29955115%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

publication date

29 June 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29955115%20AND%20SRC:MED&resulttype=core&format=json

The Pharmacogenomics Journal

3 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29955115%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29955115%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29955115%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

page(s)

740-748

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29955115%20AND%20SRC:MED&resulttype=core&format=json

Early pharmacological treatment of autism: a rationale for developmental treatment

3 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Treating disruptive behavior disorders with risperidone: a 1-year, open-label safety study in children and adolescents

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Initial severity and efficacy of risperidone in autism: Results from the RUPP trial.

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Effects of short- and long-term risperidone treatment on prolactin levels in children with autism

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

9-Hydroxyrisperidone-Induced Hyperprolactinaemia in Thai Children and Adolescents with Autism Spectrum Disorder

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Antipsychotic-induced hyperprolactinemia and testosterone levels in boys

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Hyperprolactinemia in Children and Adolescents with Use of Risperidone: Clinical and Molecular Genetics Aspects

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Population pharmacokinetic analysis of risperidone and 9-hydroxyrisperidone with genetic polymorphisms of CYP2D6 and ABCB1.

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Genetics-Based Population Pharmacokinetics and Pharmacodynamics of Risperidone in a Psychiatric Cohort

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Population pharmacokinetics of oral risperidone in children, adolescents and adults with psychiatric disorders

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Influence of ABCB1 genetic polymorphisms on the pharmacokinetics of risperidone in healthy subjects with CYP2D6*10/*10

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Impact of Pharmacogenetic Markers of CYP2D6 and DRD2 on Prolactin Response in Risperidone-Treated Thai Children and Adolescents With Autism Spectrum Disorders

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

The Affymetrix DMET Plus platform reveals unique distribution of ADME-related variants in ethnic Arabs

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Risperidone: a review of its use in the treatment of irritability associated with autistic disorder in children and adolescents

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Reference ranges for serum concentrations of lutropin (LH), follitropin (FSH), estradiol (E2), prolactin, progesterone, sex hormone-binding globulin (SHBG), dehydroepiandrosterone sulfate (DHEAS), cortisol and ferritin in neonates, children and youn

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

DNA microarrays: revolutionary insight into the living genome

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

DMET microarray technology for pharmacogenomics-based personalized medicine

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Genotyping performance between saliva and blood-derived genomic DNAs on the DMET array: a comparison

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Haploview: analysis and visualization of LD and haplotype maps

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Estimating parent-specific QTL effects through cumulating linked identity-by-state SNP effects in multiparental populations.

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

TaqMan® drug metabolism genotyping assays for the detection of human polymorphisms involved in drug metabolism

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Concordance of DMET plus genotyping results with those of orthogonal genotyping methods

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Glucuronidation enzymes, genes and psychiatry

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Clinically significant psychotropic drug-drug interactions in the primary care setting

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

Application of microarray technology in psychotropic drug trials

1 reference

https://api.crossref.org/works/10.1038%2FS41397-018-0031-7

7 January 2021

10.1038/S41397-018-0031-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29955115%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29955115%20AND%20SRC:MED&resulttype=core&format=json